Europe Neuropathic Pain Market Size & Outlook, 2025-2033


Europe Neuropathic Pain Market Insights

  • As per Reed Intelligence insights, Europe’s Neuropathic Pain Market was valued at USD 2326.71 Million in 2024 and is anticipated to expand to USD 3580.28 Million by 2033.
  • From 2026 to 2033, the market is anticipated to expand at a CAGR of 4.88%.
  • Within By Type, Peripheral Neuropathy accounted for the largest market size in 2024.
  • During the forecast period, Peripheral Neuropathy is anticipated to remain the highest-growth segment within the By Type category.

Other Key Findings


  • In 2024, Europe accounted for 26.38% of the global Neuropathic Pain Market size.
  • By 2033, United States is projected to lead the global market in terms of market size.
  • Russia is projected to emerge as the fastest-growing market in Europe, reaching USD 415.75 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 2326.71 Million
Market Size In 2033 USD 3580.28 Million
Largest segment Peripheral Neuropathy
Units Revenue in USD Million
CAGR 4.88% (2025-2033)
Segmnetation Covered
Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Nordic
  8. Benelux
By Type
  1. Peripheral Neuropathy
  2. Proximal Neuropathy
  3. Focal Neuropathy
  4. Autonomic Neuropathy
By Treatment
  1. Drug-Based
  2. Non-Drug Based
  3. By Route of Administration
  4. By Distribution Channel
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports